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Abstract Rapid degradation of specific regulatory proteins plays a role in a wide range of cellular phenomena, including cell cycle progression and 
the regulation of cell growth and differentiation. A major mechanism of selective protein turnover in vivo involves a large multi-subunit protease 
known as the proteasome or multi-catalytic proteinase. At the same time, the degradation of many cellular proteins requires their covalent ligation 
to the polypeptide ubiquitin. Here we show that the yeast S. cerevisiae MATa repressor, which is known to be ubiquitinylated in vivo, requires the 
proteasome for its rapid intracellular proteolysis. 
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1. Introduction 
Protein degradation is an essential component of many cellu- 
lar regulatory mechanisms. In eukaryotes, much of the nonspe- 
cific turnover of normally long-lived cellular proteins occurs in 
the lysosome (vacuole); various stress conditions, e.g. starva- 
tion, lead to a marked increase in lysosomal/vacuolar prote- 
olytic rates [l-4]. On the other hand, a large fraction of 
normally short-lived cellular proteins are degraded by the pro- 
teasome, an essential, high molecular weight, multi-subunit 
proteinase located in both the cytoplasm and nucleus [S-8]. 
Studies with the yeast Saccharomyces cerevisiae have led to the 
discovery of the first in vivo substrates of the proteasome. 
These substrates include both unassembled and abnormal pro- 
teins [9] as well as naturally short-lived proteins whose turnover 
is regulated either by changes in growth conditions [lo, 111 or 
by progression through the cell cycle [12-151. 
It has been shown that for many short-lived proteins, conju- 
gation to ubiquitin is an obligatory step in their degradation 
[ 16181. Ubiquitin is an evolutionarily conserved 76-residue 
polypeptide, the carboxyl-terminus of which forms isopeptide 
linkages with the &-amino groups of lysine residues in substrate 
proteins. The degradation of at least some ubiquitinylated pro- 
teins has been shown to be dependent on the proteasome in vivo 
[68,19,20]; in these cases, the proteasome is thought to func- 
tion in the context of a still larger protease complex, the so- 
called 26s protease [l&17]. Recently, Ishida et al. [21] have 
shown that the Mos protein kinase, which is known to be 
ubiquitinylated in vivo, can be degraded by the 26s enzyme in 
vitro. 
Cell identity in S. cerevisiae is governed by the mating type, 
or MAT, locus. We have found that the MATa transcriptional 
repressor, which is encoded by the MATa locus and is required 
for repression of a cell-specific genes in a cells, has an in vivo 
half-life of -4 min at 30°C [22]. The a2 protein is multiply 
ubiquitinylated in vivo, and attachment of a multi-ubiquitin 
chain to a2 is important for its rapid degradation [23,24]. At 
least four different ubiquitin-conjugating enzymes, Ubc4, 
Ubc5, Ubc6, and Ubc7, participate in the targeting of a2 for 
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ubiquitin-dependent urnover [24]. The a2 repressor has been, 
until recently at least, the only endogenous protein known to 
be ubiquitinylated in S. cerevisiae cells, although the list of such 
substrates is likely to expand considerably over the next few 
years. Here we show that the proteasome is necessary for the 
rapid degradation of the a2 repressor in vivo. The a2 protein 
is the first naturally short-lived ubiquitinylated protein to be 
shown to also be an in vivo substrate of the proteasome. 
2. Materials and methods 
2.1. Chemicals 
The proteinase inhibitors pepstatin A, chymostatin, antipain, le- 
upeptin and aprotinin were obtained from the Peptide Institute (Osaka, 
Japan) or Sigma (St. Louis, MO). [‘*S]methionine was obtained from 
Amersham (Braunschweig, Germany or Arlington Heights, IL). Yeast 
nitrogen base without amino acids was purchased from Difco (Detroit, 
USA). Antibodies against carboxypeptidase yscY (CPY) were de- 
scribed in [25]. The antibodies to the MATa repressor were described 
in [22]. Other chemicals were obtained from Pharmacia (Freiburg, Ger- 
many), Roth (Karlsruhe, Germany), Merck (Darmstadt, Germany) 
and Serva (Heidelberg, Germany). 
2.2. Media 
Complete minimal (CM) dropout medium was prepared according 
to Ausbubel et al. [26], containing 0.67% yeast nitrogen base without 
amino acids and 2% glucose, supplemented with adenine, uracil and 
amino acids. 
2.3. Strains 
Yeast strains used were: WCG4a (MATa his3-II,15 ura3 let&3.112 
CANsGAL); WCG4-1 la (MATa prel-1 his3311.15 ura3 let&3,112 
CANS GAL); WCG4-22a (MATa pre2-2 his3-II,15 ma3 leti-3,112 
CANS GAL); WCG4-11122a (MATu prel-1 pre2-2 his3-II,15 ura3 
leuZ3,112 CAN’ GAL); YBR-41a (MATa pre4-I his3-11,15 ma3 
leuZ3.112 CANS GAL); YS18 (MATa ura3A5 his3-II,15 leu2-3,112) 
and 9Sl45D (MATa prel-I ura3A5 his33II,15 let&3,Il2). 
2.4. Molecular biological techniques and plasmids 
Isolation, purification and analysis of DNA were carried out accord- 
ing to standard procedures [27]. For transformation, either a standard 
protocol [26] or a modified protocol [6] was followed. All yeast strains 
except YS18 and 95/45D were transformed with a high copy YEPl3- 
based MATa plasmid [28] that expressed the MATcc2 protein. 
2.5 Immunoprecipitation and pulse-chase assays 
Labeling of cells, preparation of cell extracts, immunoprecipitation 
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with antisera specific for MATa and for carboxypeptidase y cY, SDS- 
PAGE and flu&ography were done as described b; Hochstrasser and 
Varshavskv 1221. Prior to labeline. cells were crown 24 hat 30°C in CM 
medium. ifierer’centrifugation c& were diluied into fresh, prewarmed . . . 
CM mednun yleldmg an OD,,,,, of 0.5 and incubated for 3-5 h at 
temperatures a outlined in the figure legends. Degradation rates of 
MATa were measured as follows: the “S content of the MATa 
repressor protein was determined by a gel scanner from dried, scintil- 
lant-impregnated gels containing the immunoprecipitated MATa pro- 
tein. Radioactivity was plotted on a semilogarithmic graph. The radio- 
activity at time point zero (t = 0 min) was set to 100%. 
For the experiments examining degradation of a2 expressed only 
from the chromosomal MATa locus (Fig. 1), overnight 3O“C cultures 
in CM medium were diluted to an initial OD, of 0.2, grown for 5 h 
at 3O”C, and then grown for another 3 h at 38°C. Pulse-chase analysis 
was done at 38°C. Degradation rates were determined using excised 
a2-containing gel fragments to measure ‘5S content by scintillation 
counting, as described previously [24]. 
3. Results and discussion 
Because the yeast MATa repressor is extremely short-lived 
in vivo and must be ubiquitinylated prior to degradation [22- 
24] and because the proteasome has been implicated in ubiquiti- 
nylated protein turnover (see section 2), we examined the pos- 
sibility that the proteasome is involved in the degradation of the 
a2 protein. We conducted pulse-chase experiments to follow 
the degradation of a2 in both wild-type and mutant cells defec- 
tive for particular peptidase activities of the multi-catalytic pro- 
teasome. Yeast mutants bearing mutations in different subunits 
of the proteasome were previously shown to have substantially 
lost their ability to cleave specific chromogenic and fluorogenic 
peptide substrates. The prel-1 and pre2-2 mutants show de- 
fects in the proteasome’s chymotrypsin-like activity, whereas 
pre4-1 mutants are defective for the peptidyl-glutamyl-peptide 
cleaving activity of the protease [6,19,20]. 
Strains bearing mutations in PREI and/or PRE2 were previ- 
ously found to be defective in the turnover of artificial protein 
substrates known to be multi-ubiquitinylated in yeast cells [7,8], 
but the extent to which bulk high molecular mass ubiquitinyl- 
ated proteins accumulated in the different mutants varied con- 
siderably [19,20]. None of the mutants showed any obvious 
wild-type prel-1 
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Fig. 1. Inhibition of MATa degradation in a prel-I proteasomal 
mutant. Following 3 h of growth at 38°C Dulse-chase analysis was 
done as described in se&n 2. Cells were-labeled for 5 kin with 
1’5S1Translabel and chased for the indicated oeriods of time (min) at 
38°C. MATa protein was immunoprecipitatkd with an aftinky-pki- 
fied anti-a2 antibody 1221. (Ubiquitinylated a2 protein is generally 
difficult to detect using the experimental protocol described in section 
2 - see [23].) The calculated half-life of a2 was 6.2 min in wild-type 
(YS18) and 60 min in prel-I (95/4-5D) cells under these conditions. 
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Fig. 2. In vivo degradation of the MATa repressor in wild-type cells 
and in cells with proteasomal mutations. Isogenic wild-type and mutant 
strains carried the plasmid YEpl3::MATa and were grown and diluted 
as described in section 2. After incubation for 5 h at 38”C, cells of the 
strains WCG4a (wild-type) (A), WCG4-1 la (prel-1) (B), and WGG4- 
11122a (prel-1 pre2-2) (C) were labeled with r5S]methionine for 5 min 
and chased at 39°C for the indicated times (min). Preparation of cell 
extracts, immunoprecipitation, SDS-PAGE and fluorography were 
done as outlined in section 2. 
accumulation of ubiquitinylated proteins at a growth tempera- 
ture of 30°C. While the single prel-I mutant exhibited a mod- 
erate increase in the steady state levels of bulk multi-ubiquiti- 
nylated proteins under stress conditions (either growth in the 
presence of the amino acid analog canavanine or at high tem- 
perature (37OC)), thepre2-2 mutant showed very little accumu- 
lation of such proteins. However, introduction of the pre2-2 
mutation into a prel-I strain lead to a pronounced increase in 
the levels of high molecular mass ubiquitinylated proteins 
under these conditions [ 191. Interestingly, pre4-I cells, despite 
being completely defective in the peptidyl-glutamyl-peptide 
splitting activity of the proteasome, as measured with the chro- 
mogenic peptide Cbz-Leu-Leu-Glu-D-naphthylamide, did not 
accumulate high molecular mass ubiquitinylated proteins [20]. 
However, when introduced into a prel-I mutant strain, the 
pre4-I mutation increased the levels of these apparent prote- 
olytic intermediates relative to those seen in the single prel-I 
mutant [20]. 
When yeast cells were grown and labeled at 30°C with 
[35S]methionine and thereafter chased with nonradioactive 
methionine at the same temperature, only a weak stabilization 
of the a2 repressor could be found in prel-I cells relative to 
wild-type cells (not shown). However, incubation of cells at 
38°C prior to labeling and pulse-chase analysis at the same 
temperature (using an antibody affinity-purified against a2 
protein for immunoprecipitation [22]) revealed a strong stabili- 
zation (-lo-fold) of a2 in the prel-I mutant relative to the 
parental wild-type cells (Fig. 1). The accentuation of the prote- 
olytic defect at 38°C is consistent with the exacerbation of 
phenotypic abnormalities previously noted in the prel-I mu- 
tant at high temperature [6]. 
We repeated these experiments in isogenic strains carrying 
different combinations of proteasomal mutations. To increase 
the a2 signal, we overexpressed the a2 protein from a multicopy 
MATa plasmid. As an internal control, we precipitated the 
vacuolar enzyme carboxypeptidase yscY along with a2 (Fig. 2). 
The protein bands visible on the gel in the molecular weight 
range between carboxypeptidase yscY and MATa are due to 
unspecific protein material that is precipitated by the car- 
boxypeptidase yscY antibody (not shown). Whereas in wild- 
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Fig. 3. Quantitative analysis of the degradation rates of the a2 repressor 
in wild-type and mutant strains. Immunoprecipitated proteins were 
separated by SDS-PAGE and visualized by fluorography. Levels of 
radioactive a2 protein remaining at each timepoint in pulse-chase x- 
periments with strains WCG4a (wild-type), YBR-4la @re4-I), 
WCC&I la (prel-I), WCG422a (pre2-2) and WGG4-11122a (prel- 
I pre2-2) was quantified by densitometry. 
type cells, a2 protein was degraded very rapidly at 39°C 
(t l/2 -7 min), its degradation was clearly retarded in the isogenic 
prel-1 mutant cells (Fig. 2B) and pre2-2 mutant cells (t,,2 - 14 
min) (see also Fig. 3). (While we do not know why the degree 
of stabilization of a2 in prel-I cells differed between the exper- 
iments shown in Figs. 1 and 2, we note that the strains used in 
the two sets of experiments differed as did the level of a2 
expression and the conditions used for cell growth and pulse- 
chase analysis.) 
The introduction of the pre2-2 mutation into the prel-1 
mutant strain caused a further stabilization of the a2 protein 
(Fig. 2C), a result that correlates with the increased accumula- 
tion of ubiquitinylated proteins in the prelb1 pre2-2 mutant 
relative to that seen in prel-1 cells [19]. The degree of a2 
stabilization in the double mutant relative to wild-type cells was 
-5fold (Figs. 2 and 3). Consistent with the finding that high 
molecular mass ubiquitinylated proteins do not accumulate in 
pre4-1 cells, the a2 repressor was degraded at wild-type rates 
in these same mutant cells (Fig. 3). 
Previous in vitro and in vivo data had lead to the view that 
multi-ubiquitinylated proteins are proteolyzed by a pro- 
teasome-containing protease complex [l&18]. The a2 protein 
was known to be multiply ubiquitinylated in vivo, and its deg- 
radation is strongly ubiquitin-dependent [22-241. Together with 
the data from the present paper, these results indicate that 
naturally short-lived substrates of the ubiquitin system such as 
a2 are targeted to a proteasome-dependent proteolytic pathway 
in vivo. This study uncovers the proteasome as to be a mediator 
of transcriptional regulation. Together with the findings of its 
involvement in the regulation of metabolic enzymes [lo, 1 l] and 
the cell cycle [12-141 the proteasome merges as to be a central 
tool in eukaryotic cell regulation. 
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